Company Filing History:
2 out of 6 
1 out of 136 
Years Active: 2020-2021
Title: Fiona Lyng - Innovator in Cancer Prognostics
Introduction
Fiona Lyng is a prominent inventor based in Dublin, Ireland. She has made significant contributions to the field of cancer diagnostics and treatment prediction. With a focus on utilizing advanced spectroscopy techniques, her work aims to improve patient outcomes in oncology.
Latest Patents
Fiona Lyng holds 2 patents that showcase her innovative approaches. Her first patent is titled "Method for identification of low grade cervical cytology cases likely to progress to high grade/cancer." This invention provides a method of using Raman spectroscopy to identify low-grade cervical cytology cases that are likely to progress to high-grade or cancer. The findings indicate that high-quality Raman spectra can be successfully acquired from morphologically normal appearing cells from various Thinprep® specimens. This method allows for the separation of different grades of cervical pre-cancer with good sensitivities and specificities.
Her second patent, "Prediction of therapeutic response using vibrational spectroscopy," relates to a prognostic method for analyzing biological samples from cancer patients. This method predicts a patient's response to specific cancer treatments by performing spectroscopy on the biological sample and comparing the obtained spectrum with existing data to calculate the probability of treatment response.
Career Highlights
Fiona has worked with notable institutions, including Technological University Dublin and the College of the Holy and Undivided Trinity of Queen Elizabeth Near Dublin. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Fiona has collaborated with esteemed colleagues such as Shiyamala Duraipandian and Damien Traynor. These collaborations have further enriched her research and innovation in the field of cancer diagnostics.
Conclusion
Fiona Lyng is a trailblazer in the realm of cancer prognostics, with her innovative patents paving the way for improved diagnostic methods and treatment predictions. Her contributions are vital in enhancing the understanding and management of cancer, ultimately benefiting patients worldwide.